Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

ALX Oncology and Tallac Therapeutics Announce Collaboration on Novel Class of Cancer Immunotherapeutics

Friday, March 05, 2021

ALX Oncology Holdings Inc a clinicalstage immunooncology company developing therapies that block the CD checkpoint pathway and Tallac Therapeutics Inc Tallac a privately held biopharmaceutical company harnessing the power of innate and adaptive immun...

Tempest Therapeutics Announces Clinical Collaboration with Roche to Advance TPST-1120 into a Randomized Combination Study in First-line Hepatocellular Carcinoma

Thursday, March 04, 2021

Tempest Therapeutics Inc a clinicalstage oncology company developing firstinclass therapeutics that combine both precision and immunemediated mechanisms today announced a clinical collaboration agreement with F HoffmannLa Roche Ltd

Eisai to Support Construction of Screening Framework for the Novel Coronavirus Infection in Kenya

Thursday, March 04, 2021

Eisai Co Ltd announced today that it has decided to assent to and support a project led by CA Medlynks Kenya Ltd a subsidiary of the healthcare startup company engaged in improving healthcare access in Africa Connect Afya Co Ltd which aims to build a...

Vaxalto Biotherapeutics and Mount Sinai Enter into Exclusive License Agreement

Thursday, March 04, 2021

Vaxalto Biotherapeutics Inc wwwvaxaltocom a preclinical stage biotechnology company focused on developing and commercializing novel engineered immunotherapeutic oncolytic viruses and Mount Sinai Innovation Partners MSIP

Iktos Announces Collaboration With Pfizer in AI for Drug Design

Wednesday, March 03, 2021

Iktos announced the application of Iktos Artificial Intelligence technology for de novo design to selected Pfizer smallmolecule discovery programsOver the last few years phenomenal advances in AI algorithmic development and computational power have e...

Oscotec and Beactica Therapeutics announce license and collaboration agreement to develop new cancer drug

Wednesday, March 03, 2021

Oscotec Inc the Korean drug development company and Beactica Therapeutics AB the Swedish drug discovery company announced a new research development and licensing agreement Oscotec and Beactica will initially jointly collaborate concerning research a...

Debiopharm Grants a Worldwide Exclusive License to Merck KGaA, Darmstadt, Germany for the Development and Commercialization of Xevinapant

Tuesday, March 02, 2021

Debiopharm wwwdebiopharmcom a Swissbased global biopharmaceutical company announced the signature of an exclusive license agreement with Merck KGaA Darmstadt Germany a leading science and technology company for the development and commercialization...

Phio Pharmaceuticals and AgonOx, Inc. Announce Collaboration on Clinical Development of Novel T Cell-based Cancer Immunotherapies

Tuesday, March 02, 2021

Phio Pharmaceuticals Corp a biotechnology company developing the next generation of immunooncology therapeutics based on its proprietary selfdelivering RNAi therapeutic platform announced it has entered into a clinical development collaboration with...

HitGen and UPPTHERA Enter Into Drug Discovery Research Collaboration

Monday, March 01, 2021

HitGen announced that it has entered into a drug discovery research collaboration with UPPTHERA Inc to identify small molecule Hits against previous knowntobe undruggable targets and novel E ligase HitGen will apply its platform technology based on t...

Pharmaron Acquires State-of-the-Art Biomanufacturing Site in the United Kingdom from AbbVie

Monday, March 01, 2021

Pharmaron Beijing Co Limited announced that it has entered into a definitive agreement to acquire Allergan Biologics Limited The ABL site in Liverpool UK for US million in cash from AbbVie The transaction is expected to close in the second quarter of...